pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 29·1 min read
save

Kenyan court halts U.S. plan for Ebola quarantine facility for Americans

May 29, 2026·read at STAT ↗RegulatoryNegative

A Nairobi High Court on Friday ordered a stop to a U.S. proposal to build a quarantine center in Kenya for Americans who might have been exposed to a rare Ebola strain circulating in northeastern Congo.

The plan, described by an anonymous U.S. administration official, would have sent exposed travelers to the Kenyan facility instead of repatriating them. The location of the center and whether Kenyan authorities had approved it were not disclosed.

The court's injunction will remain in effect until petitions filed by the Katiba Institute, a constitutional watchdog, and the Kenya Law Society are heard on Tuesday. The Kenyan government has only acknowledged broader discussions on Ebola preparedness and a $13.5 million U.S. contribution to those efforts.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Kenya court suspends U.S. plan for Ebola quarantine facility for Americans”

read at STAT ↗
572 words · retrieved Jun 2
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Ultragenyx Pharmaceutical Inc.3
topics
Rare Disease3Oncology2HematologyInfectious DiseaseNSCLCPulmonologyVaccine

related stories

  • 1d agoCaribou layoffs could wipe out 90% of staffBioSpace
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Dec 22Fierce Biotech Fundraising Tracker '26: Matchpoint makes $150M; KymaThera corrals $80MFierce Biotech
  • Sep 10Andy Plump, architect of Takeda’s R&D overhaul, to retire next yearBioPharma Dive
  • Aug 14Capricor shares spike on CEO comments; Cytokinetics sues Bristol MyersBioPharma Dive